Quantcast

Daily Archives: February 12, 2007

tpxsalaries.jpg

TPX: Tempur-Pedic Tries to Sneak by Management Raises

By William Trent, CFA of Stock Market BeatWe noted recently that Small Cap Watch List and Mid Cap Watch List member Tempur-Pedic (TPX) is on a tear lately. Of course, ...
Read Full Story »

MU: Micron Misses, and We’re Dying of Not-Surprise

By William Trent, CFA of Stock Market Beat“There’s a big surprise! I think I’m gonna have a heart attack, and die of not-surprise!” - The parrot Iago (voice by Gilbert ...
Read Full Story »

Dell’s “New” CEO

From The Average Joe InvestorBack in May, I posted on Dell's (Nasdaq: DELL) troubles. At the time, I didn't really think too much of the shares and didn't own any ...
Read Full Story »

IDCC- A Real Fortress

From Value DisciplineThe Street went into heat last week to celebrate the inauguration of the first NYSE listed hedge fund manager, Fortress Group (FIG.) The 67.6% rise on the intial ...
Read Full Story »

http://www.biohealthinvestor.com/

By Yaser Anwar, CSC of Equity Investment IdeasThis is a first in a two part series pertaining to The Oil Outlook. This week we look at the supply side issues, ...
Read Full Story »

Raggedy Ann and the Anti-Vaccination Movement

by H.S. AyoubBioHealth Investor.comIt was in 1796 that Edward Jenner successfully immunized a child against smallpox, and his experiment introduced the word ‘vaccination’. This event motivated a tremendous movement by ...
Read Full Story »

Q3 is Key for Thermogenesis

Thermogenesis Corp (KOOL), a developer of cord blood collection and processing units, released subpar fiscal second quarter results on Friday. While earnings increased by 19%, net profit dropped by more ...
Read Full Story »

Gilead Q4 Report: Preview of Great Things to Come

by JMHOBioTechnology Stock BlogGilead (GILD) is a large biotech company with a portfolio of marketed products that include royalties from the blockbuster Tamiflu for treatment and prevention of influenza, as ...
Read Full Story »